You are here

Pharmaceutical Drug Delivery Market, 2023 - Opportunities in Self-Administration and Home Care & Rising Demand for Biosimilars

DUBLIN, March 22, 2019 /PRNewswire/ -- The "Pharmaceutical Drug Delivery Market by Route and Application - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period.

Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. On the other hand, the risk of needlestick injuries and the increasing pricing pressure are expected to challenge market growth in the coming years.

"The home care settings segment is expected to grow at the highest CAGR during the forecast period."

Based on the facility of use, the pharmaceutical drug delivery market is segmented hospitals, ambulatory surgical centres (ASCs)/clinics, diagnostic centres, home care settings, and other facilities of use. The home care settings segment is expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to increasing use of various drug delivery devices such as injectables, nebulizers, and inhalers in home care settings.

"The conventional injection devices segment accounted for the largest share of the injectable drug delivery market in 2018." 

Based on the type, the injectable drug delivery technology is segmented into conventional injection devices, self-injection devices, and other devices. In 2018, conventional injection devices accounted for the largest share of the injectable drug delivery technology market. The large share of this segment can primarily be attributed to factors such as the low cost of devices and manufacturing, large molecular size of biologics administered through injectables, and the widespread popularity of conventional devices.

"North America to dominate the market during the forecast period."

In 2018, North America accounted for the largest share of the pharmaceutical drug delivery market. The large share of the North American market is due to factors such as the rising prevalence of chronic diseases such as cancer, respiratory allergies, and diabetes; growth in biologics in the pharmaceuticals market; and the presence of a large number of prominent players in this region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Drug Delivery Technology: Market Overview
4.2 Drug Delivery Technology Market, By Route of Administration, 2018 Vs. 2023 (USD Billion)
4.3 Drug Delivery Technology Market, By Facility of Use, 2018-2023 (USD Billion)
4.4 Drug Delivery Technology Market Share, By Application and Region, 2018
4.5 Drug Delivery Technology Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Rising Prevalence of Chronic Diseases
5.3.2 Growth in the Biologics Market
5.3.3 Technological Advancements and New Product Launches
5.4 Restraints
5.4.1 Risk of Needlestick Injuries
5.5 Opportunities
5.5.1 Self-Administration and Home Care
5.5.2 Rising Demand for Biosimilars
5.6 Challenges
5.6.1 Pricing Pressure

6 Drug Delivery Technology Market, By Route of Administration
6.1 Introduction
6.2 Oral Drug Delivery
6.2.1 Solid Oral Drugs
6.2.1.1 Tablets
6.2.1.2 Capsules
6.2.1.3 Powders
6.2.1.4 Pills
6.2.2 Liquid Oral Drugs
6.2.2.1 Syrups
6.2.2.2 Solutions
6.2.3 Semi-Solid Oral Drugs
6.2.3.1 Gels
6.2.3.2 Emulsions
6.2.3.3 Elixirs
6.3 Injectable Drug Delivery
6.3.1 Conventional Injection Devices
6.3.1.1 By Material
6.3.1.1.1 Glass
6.3.1.1.2 Plastic
6.3.1.2 By Product
6.3.1.2.1 Fillable Syringes
6.3.1.2.2 Prefilled Syringes
6.3.1.3 By Usability
6.3.1.3.1 Reusable Syringes
6.3.1.3.2 Disposable Syringes
6.3.2 Self-Injection Devices
6.3.2.1 Needle-Free Injectors
6.3.2.2 Autoinjectors
6.3.2.3 Pen Injectors
6.3.2.4 Wearable Injectors
6.3.3 Other Injector Devices
6.4 Topical Drug Delivery
6.4.1 Liquid Formulations
6.4.1.1 Solutions
6.4.1.2 Suspensions
6.4.2 Semi-Solid Formulations
6.4.2.1 Creams
6.4.2.2 Gels
6.4.2.3 Ointments
6.4.2.4 Pastes
6.4.2.5 Lotions
6.4.3 Solid Formulations
6.4.3.1 Suppositories
6.4.3.2 Powders
6.4.4 Transdermal Products
6.4.4.1 Transdermal Patches
6.4.4.2 Transdermal Gels
6.5 Ocular Drug Delivery
6.5.1 Liquid Formulations
6.5.1.1 Eye Drops
6.5.1.2 Liquid Sprays
6.5.2 Semi-Solid Formulations
6.5.2.1 Gels
6.5.2.2 Eye Ointments
6.5.3 Ocular Devices
6.5.3.1 Drug-Coated Contact Lenses
6.5.3.2 Ocular Inserts
6.6 Pulmonary Drug Delivery
6.6.1 Metered-Dose Inhalers
6.6.2 Dry Powder Inhalers
6.6.2.1 Dpi Drug Formulations are Chemically More Stable Than Their Counterparts Are
6.6.3 Nebulizers
6.6.3.1 Jet Nebulizers
6.6.3.2 Ultrasonic Nebulizers
6.6.3.3 Soft Mist Nebulizers
6.7 Nasal Drug Delivery
6.7.1 Nasal Drops
6.7.2 Nasal Sprays
6.7.3 Nasal Powders
6.7.4 Nasal Gels
6.8 Transmucosal Drug Delivery
6.8.1 Oral Formulations
6.8.2 Other Transmucosal Drug Delivery Technologies
6.9 Implantable Drug Delivery
6.9.1 Active Implantable Drug Delivery
6.9.2 Passive Implantable Drug Delivery

7 Drug Delivery Technology Market, By Patient Care Setting
7.1 Introduction
7.2 Hospitals
7.2.1 Hospitals Will Continue to Dominate the Drug Delivery Technology Market During the Forecast Period
7.3 Ambulatory Surgery Centers/Clinics
7.3.1 Increasing Preference for ASCS has Resulted in A Significant Rise in Demand for Drug Delivery Technologies
7.4 Home Care Settings
7.4.1 Home Care Settings to Register the Highest Growth Rate During the Forecast Period
7.5 Diagnostic Centers
7.5.1 Rising Prevalence of Chronic Diseases to Support Market Growth
7.6 Other Facilities of Use

8 Drug Delivery Technology Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.2.1 High Burden of Infectious Diseases Across the Globe to Drive Market Growth
8.3 Cancer
8.3.1 Cancer Forms A Key Therapeutic Application Segment for Drug Delivery Technologies
8.4 Cardiovascular Diseases
8.4.1 Increasing Prevalence of Cvds is Driving the Growth of the Drug Delivery Technology Market
8.5 Diabetes
8.5.1 Emergence of New Technologies is Supporting Market Growth
8.6 Respiratory Diseases
8.6.1 High Prevalence of Asthma & Copd to Drive the Adoption of Drug Delivery Technologies
8.7 Central Nervous System Disorders
8.7.1 Oral and Injectable Drug Delivery Systems are Widely Used in the Treatment of Cns Disorders
8.8 Autoimmune Diseases
8.8.1 Autoimmune Diseases Segment to Register the Highest Growth in the Forecast Period
8.9 Other Applications
8.9.1 Ophthalmic Disorders
8.9.2 Endocrine Disorders

9 Drug Delivery Technology Market, By Region

10 Competitive Landscape
10.1 Overview
10.2 Market Player Ranking, 2017
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (2017)
10.5 Competitive Leadership Mapping for Start-Ups (2017)

11 Company Profile
11.1 Johnson & Johnson Services, Inc.
11.2 Novartis AG
11.3 F. Hoffmann-La Roche Ltd.
11.4 Pfizer, Inc.
11.5 Bayer AG
11.6 Antares Pharma, Inc.
11.7 Becton, Dickinson and Company
11.8 GlaxoSmithKline PLC
11.9 3M
11.10 Merck & Co., Inc.
11.11 Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/2cqrbn/pharmaceutical?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/pharmaceutical-drug-delivery-market-2023---opportunities-in-self-administration-and-home-care--rising-demand-for-biosimilars-300817032.html

SOURCE Research and Markets